Autoimmune hepatitis with incidental histologic features of bile duct injury

Hepatology

Volumn 34, Issue 4 I, 2001, Pages 659-665

  Czaja, Albert J ^a   Carpenter, Herschel A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT INJURY; CHOLANGITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034807020     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.27562     Document Type: Article

References (44)

1. Meeting Report
2. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis
3. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis
4. Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis
5. The nature and prognostic implications of autoimmune hepatitis with an acute presentation
6. Recent onset autoimmune hepatitis: Biopsy findings and clinical correlations
7. Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution
8. Histologic features in autoimmune hepatitis
9. A novel histological lesion in glucocorticoid-responsive chronic hepatitis
10. Autoimmune hepatitis: A histological variant associated with prominent centrilobular necrosis
11. Autoimmune hepatitis
12. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary disease: Morphologic spectrum, clinical correlations and terminology
13. Autoimmune cholangitis within the spectrum of autoimmune liver disease
14. Chronic active hepatitis: The challenge for a new nomenclature
15. The variant forms of autoimmune hepatitis
16. Frequency and nature of the variant syndromes of autoimmune liver disease
17. The occurrence and significance of abnormal bile duct epithelium in chronic aggressive hepatitis
18. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome
19. The validity and importance of subtypes of autoimmune hepatitis: A point of view
20. Genetic predispositions for the immunological features of chronic active hepatitis
21. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis
22. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis
23. Autoantibodies in liver disease
24. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis
25. Prednisone for chronic active liver disease: Dose titration, standard dose, and combination with azathioprine compared
26. Drug therapy in the management of type 1 autoimmune hepatitis
27. Validation of a scoring system for the diagnosis of autoimmune hepatitis
28. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy
29. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis
30. Histological grading and staging of chronic hepatitis
31. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
32. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis
33. Autoimmune cholangitis with features of autoimmune hepatitis: Successful treatment with immunosuppressive agents and ursodeoxycholic acid
34. Primary autoimmune cholangitis: An alternative to antimitochondrial antibody-negative primary biliary cirrhosis
35. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Corticoresistance and effective treatment with cyclosporine A
36. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
37. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals
38. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis
39. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis
40. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis
41. Autoimmune hepatitis overlapping primary sclerosing cholangitis in five cases
42. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis
43. Overlap syndrome between autoimmune hepatitis and primary sclerosing cholangitis in two cases
44. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis